ID FAXD1_NOTSC Reviewed; 455 AA. AC P82807; Q4F879; DT 19-SEP-2003, integrated into UniProtKB/Swiss-Prot. DT 28-JUN-2011, sequence version 2. DT 02-SEP-2026, entry version 128. DE RecName: Full=Venom prothrombin activator notecarin-D1; DE Short=vPA; DE EC=3.4.21.6; DE AltName: Full=Venom coagulation factor Xa-like protease; DE Contains: DE RecName: Full=Notecarin-D1 light chain; DE Contains: DE RecName: Full=Notecarin-D1 heavy chain; DE Flags: Precursor; OS Notechis scutatus scutatus (Eastern tiger snake) (Naja scutata scutata). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera; OC Serpentes; Colubroidea; Elapidae; Hydrophiinae; Notechis. OX NCBI_TaxID=70142; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Venom gland; RA Panizzi P.R., Panizzi J.R., Bock P.E.; RT "Notecarin D, a prothrombin activator and factor Xa-like protease."; RL Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases. RN [2] RP PROTEIN SEQUENCE OF 41-80; 210-247 AND 296-315, FUNCTION, SUBCELLULAR RP LOCATION, TISSUE SPECIFICITY, AND GAMMA-CARBOXYGLUTAMATION AT GLU-46; RP GLU-47; GLU-54; GLU-56; GLU-59; GLU-60; GLU-65; GLU-66; GLU-69; GLU-72 AND RP GLU-75. RC TISSUE=Venom; RX PubMed=10779512; DOI=10.1074/jbc.m002298200; RA Brown M.A., Stenberg L.M., Persson U., Stenflo J.; RT "Identification and purification of vitamin K-dependent proteins and RT peptides with monoclonal antibodies specific for gamma-carboxyglutamyl RT (Gla) residues."; RL J. Biol. Chem. 275:19795-19802(2000). RN [3] RP PROTEIN SEQUENCE OF 41-76 AND 210-235, FUNCTION, SUBCELLULAR LOCATION, RP TISSUE SPECIFICITY, GAMMA-CARBOXYGLUTAMATION AT GLU-46; GLU-47; GLU-54; RP GLU-56; GLU-59; GLU-60; GLU-65; GLU-66; GLU-69; GLU-72 AND GLU-75, AND RP IDENTIFICATION BY MASS SPECTROMETRY. RC TISSUE=Venom; RX PubMed=12403650; DOI=10.1042/bj20020889; RA Rao V.S., Joseph J.S., Kini R.M.; RT "Group D prothrombin activators from snake venom are structural homologues RT of mammalian blood coagulation factor Xa."; RL Biochem. J. 369:635-642(2003). RN [4] RP NOMENCLATURE. RX PubMed=11522026; DOI=10.1055/s-0037-1616108; RA Manjunatha Kini R., Morita T., Rosing J.; RT "Classification and nomenclature of prothrombin activators isolated from RT snake venoms."; RL Thromb. Haemost. 86:710-711(2001). CC -!- FUNCTION: Snake prothrombin activator that attacks the hemostatic CC system of prey. This protein is functionally similar to blood CC coagulation factor Xa. {ECO:0000269|PubMed:10779512, CC ECO:0000269|PubMed:12403650}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Selective cleavage of Arg-|-Thr and then Arg-|-Ile bonds in CC prothrombin to form thrombin.; EC=3.4.21.6; CC -!- SUBUNIT: Heterodimer of a light chain and a heavy chain; disulfide- CC linked. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10779512, CC ECO:0000269|PubMed:12403650}. CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC {ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650}. CC -!- PTM: Gamma-carboxyglutamate residues are formed by vitamin K dependent CC carboxylation. These residues are essential for the binding of calcium. CC {ECO:0000255|PROSITE-ProRule:PRU00463, ECO:0000269|PubMed:10779512, CC ECO:0000269|PubMed:12403650}. CC -!- MISCELLANEOUS: Is classified in the group D of snake venom prothrombin CC activators, since it requires the mammalian factor Va for maximal CC activity for the cleavage of prothrombin. The venom of this species CC does not contain its own coagulation factor V-like. CC -!- MISCELLANEOUS: 2 isoforms of notecarin D (D1 and D2) are described in CC PubMed:12403650. We chose to name this protein D1 according to the CC masses indicated in the paper. CC -!- MISCELLANEOUS: In contrast to blood coagulation factors that circulate CC as inactive zymogen in plasma, venom prothrombin activators are always CC found in the active form in the venom. CC -!- SIMILARITY: Belongs to the peptidase S1 family. Snake venom subfamily. CC {ECO:0000255|PROSITE-ProRule:PRU00274}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; DQ104218; AAZ14091.1; -; mRNA. DR AlphaFoldDB; P82807; -. DR SMR; P82807; -. DR MEROPS; S01.426; -. DR GO; GO:0005576; C:extracellular region; IDA:UniProtKB. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB. DR GO; GO:0007596; P:blood coagulation; IEA:InterPro. DR GO; GO:0006508; P:proteolysis; IEA:InterPro. DR GO; GO:0044469; P:venom-mediated blood coagulation; IDA:UniProtKB. DR CDD; cd00054; EGF_CA; 1. DR CDD; cd00190; Tryp_SPc; 1. DR FunFam; 2.10.25.10:FF:000513; Coagulation factor VII; 1. DR FunFam; 2.40.10.10:FF:000013; Coagulation factor X; 1. DR FunFam; 2.10.25.10:FF:000162; Coagulation factor X (Predicted); 1. DR FunFam; 4.10.740.10:FF:000001; vitamin K-dependent protein S; 1. DR Gene3D; 4.10.740.10; Coagulation Factor IX; 1. DR Gene3D; 2.10.25.10; Laminin; 2. DR Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2. DR InterPro; IPR017857; Coagulation_fac-like_Gla_dom. DR InterPro; IPR000742; EGF. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site. DR InterPro; IPR018097; EGF_Ca-bd_CS. DR InterPro; IPR035972; GLA-like_dom_SF. DR InterPro; IPR000294; GLA_domain. DR InterPro; IPR012224; Pept_S1A_FX. DR InterPro; IPR050442; Peptidase_S1_coag_factors. DR InterPro; IPR009003; Peptidase_S1_PA. DR InterPro; IPR001314; Peptidase_S1A. DR InterPro; IPR001254; Trypsin_dom. DR InterPro; IPR018114; TRYPSIN_HIS. DR InterPro; IPR033116; TRYPSIN_SER. DR PANTHER; PTHR24278; COAGULATION FACTOR; 1. DR PANTHER; PTHR24278:SF28; COAGULATION FACTOR X; 1. DR Pfam; PF00008; EGF; 1. DR Pfam; PF14670; FXa_inhibition; 1. DR Pfam; PF00594; Gla; 1. DR Pfam; PF00089; Trypsin; 1. DR PIRSF; PIRSF001143; Factor_X; 1. DR PRINTS; PR00722; CHYMOTRYPSIN. DR PRINTS; PR00001; GLABLOOD. DR SMART; SM00181; EGF; 2. DR SMART; SM00179; EGF_CA; 1. DR SMART; SM00069; GLA; 1. DR SMART; SM00020; Tryp_SPc; 1. DR SUPFAM; SSF57196; EGF/Laminin; 1. DR SUPFAM; SSF57630; GLA-domain; 1. DR SUPFAM; SSF50494; Trypsin-like serine proteases; 1. DR PROSITE; PS00010; ASX_HYDROXYL; 1. DR PROSITE; PS00022; EGF_1; 1. DR PROSITE; PS50026; EGF_3; 1. DR PROSITE; PS01187; EGF_CA; 1. DR PROSITE; PS00011; GLA_1; 1. DR PROSITE; PS50998; GLA_2; 1. DR PROSITE; PS50240; TRYPSIN_DOM; 1. DR PROSITE; PS00134; TRYPSIN_HIS; 1. DR PROSITE; PS00135; TRYPSIN_SER; 1. PE 1: Evidence at protein level; KW Blood coagulation cascade activating toxin; Calcium; KW Cleavage on pair of basic residues; Direct protein sequencing; KW Disulfide bond; EGF-like domain; Gamma-carboxyglutamic acid; Glycoprotein; KW Hemostasis impairing toxin; Hydrolase; Protease; Prothrombin activator; KW Repeat; Secreted; Signal; Toxin. FT SIGNAL 1..20 FT /evidence="ECO:0000255" FT PROPEP 21..40 FT /evidence="ECO:0000250" FT /id="PRO_0000409723" FT CHAIN 41..181 FT /note="Notecarin-D1 light chain" FT /id="PRO_0000027819" FT PROPEP 182..209 FT /note="Activation peptide" FT /evidence="ECO:0000250" FT /id="PRO_0000409724" FT CHAIN 210..455 FT /note="Notecarin-D1 heavy chain" FT /id="PRO_0000027821" FT DOMAIN 41..86 FT /note="Gla" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463" FT DOMAIN 86..122 FT /note="EGF-like 1; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 129..164 FT /note="EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 210..453 FT /note="Peptidase S1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00274" FT ACT_SITE 251 FT /note="Charge relay system" FT /evidence="ECO:0000250" FT ACT_SITE 308 FT /note="Charge relay system" FT /evidence="ECO:0000250" FT ACT_SITE 405 FT /note="Charge relay system" FT /evidence="ECO:0000250" FT MOD_RES 46 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 47 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 54 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 56 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 59 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 60 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 65 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 66 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 69 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 72 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT MOD_RES 75 FT /note="4-carboxyglutamate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00463, FT ECO:0000269|PubMed:10779512, ECO:0000269|PubMed:12403650" FT CARBOHYD 92 FT /note="O-linked (Hex...) serine" FT /evidence="ECO:0000250" FT CARBOHYD 254 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 57..62 FT /evidence="ECO:0000250" FT DISULFID 90..101 FT /evidence="ECO:0000250" FT DISULFID 95..110 FT /evidence="ECO:0000250" FT DISULFID 112..121 FT /evidence="ECO:0000250" FT DISULFID 129..140 FT /evidence="ECO:0000250" FT DISULFID 136..149 FT /evidence="ECO:0000250" FT DISULFID 151..164 FT /evidence="ECO:0000250" FT DISULFID 172..328 FT /note="Interchain (between light and heavy chains)" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076, FT ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000255|PROSITE- FT ProRule:PRU00463" FT DISULFID 216..221 FT /evidence="ECO:0000250" FT DISULFID 236..252 FT /evidence="ECO:0000250" FT DISULFID 376..390 FT /evidence="ECO:0000250" FT DISULFID 401..429 FT /evidence="ECO:0000250" SQ SEQUENCE 455 AA; 51464 MW; F70377EA9A05BCD2 CRC64; MAPQLLLCLI LTFLWSLPEA ESNVFLKSKV ANRFLQRTKR SNSLFEEIRP GNIERECIEE KCSKEEAREV FEDNEKTETF WNVYVDGDQC SSNPCHYRGT CKDGIGSYTC TCLPNYEGKN CEKVLYQSCR VDNGNCWHFC KRVQSETQCS CAESYRLGVD GHSCVAEGDF SCGRNIKARN KREASLPDFV QSQKATLLKK SDNPSPDIRI VNGMDCKLGE CPWQAVLINE KGEVFCGGTI LSPIHVLTAA HCINQTKSVS VIVGEIDISR KETRRLLSVD KIYVHTKFVP PNYYYVHQNF DRVAYDYDIA IIRMKTPIQF SENVVPACLP TADFANEVLM KQDSGIVSGF GRIRFKEPTS NTLKVITVPY VDRHTCMLSS DFRITQNMFC AGYDTLPQDA CQGDSGGPHI TAYRDTHFIT GIISWGEGCA RKGKYGVYTK VSRFIPWIKK IMSLK //